| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/18/1992 | CA1306582C Synthetic polypeptides for detecting mycobacterial infections |
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/16/1992 | CA2061266A1 Recombinant dna molecules coding for a sequence of the t-cell antigen receptor, process for its preparation, and antibodies and medicament containing them |
| 08/12/1992 | EP0498767A2 Chimeric antiidiotypic monoclonal antibodies |
| 08/12/1992 | EP0498124A1 Monoclonal antibodies to mite allergen and the use thereof |
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production |
| 08/12/1992 | EP0497884A1 Glutamate receptor compositions and methods |
| 08/12/1992 | EP0497883A1 Compositions and their use for promoting immunopotentiation |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/11/1992 | US5137819 Cellulose binding fusion proteins for immobilization and purification of polypeptides |
| 08/11/1992 | CA1306209C Fused antigen polypeptide |
| 08/11/1992 | CA1306207C Polypeptide and protein products, and process for their production and use |
| 08/11/1992 | CA1306194C Use of amphipathic molecules for radio-imaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 08/07/1992 | CA2060626A1 Chimeric antiidiotypic monoclonal antibodies |
| 08/06/1992 | WO1992013096A1 Antihuman stromelysin monoclonal antibody and diagnosis of rheumatoid arthritis by enzyme immunoassay |
| 08/06/1992 | WO1992013081A1 Antigen-presenting capsid with fusion ms2-coat protein |
| 08/06/1992 | WO1992012994A1 Mixed specificity fusion proteins |
| 08/05/1992 | EP0497585A2 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/05/1992 | EP0497366A2 Antimicrobial peptides and their use against plant pathogens |
| 08/05/1992 | EP0217919B1 Type-specific papillomavirus dna sequences and peptides |
| 08/05/1992 | EP0185076B1 Hybrid protein |
| 08/04/1992 | US5136019 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 07/31/1992 | CA2060235A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 07/29/1992 | CN1063109A Improvements in and relating to hormones |
| 07/28/1992 | US5134075 Antitumor agents |
| 07/28/1992 | US5134071 Polymerization and copolymerization of proteins |
| 07/28/1992 | CA1305828C Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 07/22/1992 | EP0451206A4 Receptor transcription-repression activity compositions and methods |
| 07/21/1992 | US5132213 Method for producing proteins and polypeptides using ubiquitin fusions |
| 07/19/1992 | WO1992013097A1 Hepatic growth factor receptor is the met proto-oncogene |
| 07/15/1992 | EP0494825A1 Synthetic peptides, derived from HBc antigen of hepatitis B virus |
| 07/15/1992 | EP0494293A1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
| 07/14/1992 | US5130417 Entamoeba histolytical immunogenic protein and cdna clone |
| 07/14/1992 | US5130415 Diagnosis of cancer |
| 07/10/1992 | WO1992012247A1 Analogs of piscine lhrh |
| 07/10/1992 | CA2100057A1 Analogs of piscine lhrh |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011370A2 Polypeptides derived from proteins of the hepatitis c virus |
| 07/09/1992 | WO1992011365A1 Liver enriched transcription factor |
| 07/09/1992 | WO1992011291A1 Vaccines based on hepatitis b surface antigen |
| 07/09/1992 | WO1992011283A1 Transgenic, cross-linked hemoglobin |
| 07/09/1992 | WO1992011031A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
| 07/09/1992 | WO1992010936A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 07/09/1992 | CA2098818A1 Transgenic, cross-linked hemoglobin |
| 07/09/1992 | CA2098598A1 Adhesin-oligosaccharide conjugate vaccine for haemophilus influenzae |
| 07/08/1992 | EP0493398A1 Alkaline proteolytic enzyme and method of production |
| 07/07/1992 | US5128453 Urinary follicle stimulating hormone |
| 07/07/1992 | US5128450 Bone marrow |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/01/1992 | EP0492964A2 Cloning and expression of Borrelia lipoproteins |
| 07/01/1992 | EP0492500A2 Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP |
| 07/01/1992 | EP0491873A1 Therapeutic compositions; methods for treatment of hiv infections |
| 07/01/1992 | EP0491867A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer. |
| 06/30/1992 | US5126399 Methods and compositions for the preparation and use of site-directed immunologic reagents |
| 06/30/1992 | US5126240 Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |
| 06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
| 06/25/1992 | WO1992010591A1 Chimeric chains for receptor-associated signal transduction pathways |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | DE4041304A1 Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren Of structural proteins of the hepatitis C virus-derived polypeptides, test kits containing such polypeptides, and vaccines against infection by hepatitis C virus |
| 06/25/1992 | CA2614365A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2057761A1 Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens hrpii and serp, the preparation and use thereof |
| 06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
| 06/24/1992 | EP0491125A1 Vaccines against equine herpes viruses and their preparation |
| 06/24/1992 | EP0207963B1 Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
| 06/24/1992 | CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/23/1992 | US5124255 CKS method of protein synthesis |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
| 06/23/1992 | CA1303980C Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies and use therefor |
| 06/22/1992 | WO1992011364A1 Biosynthetic pdgf antagonists |
| 06/22/1992 | CA2097603A1 Biosynthetic pdgf antagonists |
| 06/21/1992 | WO1992011272A1 Optimization of binding proteins |
| 06/21/1992 | CA2098824A1 Optimization of binding proteins |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
| 06/16/1992 | US5122463 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor |
| 06/14/1992 | WO1992010576A1 Fusion polypeptides |
| 06/14/1992 | CA2094512A1 Fusion polypeptides |
| 06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
| 06/11/1992 | WO1992009690A2 Enrichment method for variant proteins with altered binding properties |
| 06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
| 06/11/1992 | WO1992009617A1 Cell stress transcriptional factors |
| 06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 06/11/1992 | CA2405246A1 Enrichment method for variant proteins with alterred binding properties |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120642 Medical diagnosis |
| 06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
| 06/03/1992 | EP0488170A1 Cell-free receptor binding tests, their production and use |
| 06/03/1992 | EP0488061A2 The MAC-1 binding site of ICAM-1 |
| 06/03/1992 | EP0474789A4 Cysteine thiol-protected peptides for use in immunoassays |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | CA1301674C Pseudorabies virus recombinants and their use in the production of proteins |